Cite
CD44+/CD24- phenotype predicts a poor prognosis in triple-negative breast cancer.
MLA
Hui Wang, et al. “CD44+/CD24- Phenotype Predicts a Poor Prognosis in Triple-Negative Breast Cancer.” Oncology Letters, vol. 14, no. 5, Nov. 2017, pp. 5890–98. EBSCOhost, https://doi.org/10.3892/ol.2017.6959.
APA
Hui Wang, Li Wang, Ying Song, Shuhuai Wang, Xu Huang, Qijia Xuan, Xinmei Kang, & Qingyuan Zhang. (2017). CD44+/CD24- phenotype predicts a poor prognosis in triple-negative breast cancer. Oncology Letters, 14(5), 5890–5898. https://doi.org/10.3892/ol.2017.6959
Chicago
Hui Wang, Li Wang, Ying Song, Shuhuai Wang, Xu Huang, Qijia Xuan, Xinmei Kang, and Qingyuan Zhang. 2017. “CD44+/CD24- Phenotype Predicts a Poor Prognosis in Triple-Negative Breast Cancer.” Oncology Letters 14 (5): 5890–98. doi:10.3892/ol.2017.6959.